Quantum Blue® Adalimumab

The biologic drug Adalimumab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN  Quantum Blue® Adalimumab is the first rapid test to measure adalimumab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.

Quantum Blue® Anti-Adalimumab (RUO)

The presence of anti-drug antibodies (ADA) against adalimumab might diminish the clinically beneficial effect of the drug. The Quantum Blue® Anti-Adalimumab rapid test allows for a highly sensitive detection of antibodies against adalimumab within 15 min.

Quantum Blue® Infliximab

The biologic drug Infliximab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN  Quantum Blue® Infliximab is the first rapid test to measure infliximab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.

Quantum Blue® Anti-Infliximab (RUO)

The presence of anti-drug antibodies (ADA) against infliximab might diminish the clinically beneficial effect of the drug. The Quantum Blue® Anti-Infliximab rapid test allows for a highly sensitive detection of antibodies against infliximab within 15 min.